Navigation Links
Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings
Date:6/9/2008

effects. These data, along with the significant improvements on bioavailability and pharmacodynamic effects with PI-2301, provide further evidence that PI-2301 may replace Copaxone as first-line therapy in relapsing remitting multiple sclerosis," stated Thomas P. Mathers, President and CEO of Peptimmune. "We have designed PI-2301 to maximize the therapeutic benefit of a proven, safe compound class in multiple sclerosis as well as increasing patients' convenience."

PI-2301 is a second generation peptide copolymer from a similar compound class as Copaxone. PI-2301 works through immune modulation by enhancing the regulatory response of the immune system to control the pathogenic autoimmune response in certain diseases. PI-2301 has been optimized using Peptimmune's novel platform peptide chemistry and in pre-clinical studies, has shown to be more potent and effective than Copaxone in treating disease models for multiple sclerosis. PI-2301 has also shown efficacy in pre-clinical models of autoimmune diseases where immune modulation may be effective, such as Crohn's disease, rheumatoid arthritis and autoimmune uveitis. Peptimmune has also introduced highly reproducible manufacturing methods that allow very strict control and characterization of PI-2301 and should provide a superior level of batch to batch consistency.

Over 400,000 Americans have multiple sclerosis (MS), and MS may affect over 2.5 million individuals worldwide. MS is an autoimmune disease in which the individuals' immune system responds against multiple components of nerve-insulating myelin. The effects of these immune-mediated attacks can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted.

About Peptimmune

Peptimmune, Inc. is a privately held clinical stage biotechnology company focused on the development of peptide therapies to improve the management of chronic autoimmune and inflammato
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
2. Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
3. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
4. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
5. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
6. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
7. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
8. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
9. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
10. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
11. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014  The University of Maryland,s A. James ... groundbreaking of the new A. James Clark Hall at ... will cultivate transformative new engineering and biomedical technologies to ... at 10:00 a.m. on November 21 at the site ... Lot, adjacent to the Jeong H. Kim Engineering Building, ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
(Date:11/21/2014)... PLAINFIELD, N.J. , Nov. 21, 2014  PTC Therapeutics, ... that the 2014 Legend of Technology Award for Vision, Innovation, ... , Ph.D., Chief Executive Officer. This award recognizes an individual ... in New Jersey for several decades. ... of Technology Award," stated Stuart Peltz , Ph.D., CEO ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
(Date:11/23/2014)... Tbdress.com has recently announced that its Special Friday ... The special offer will provide ladies many gorgeous shoes at ... world’s largest women’s dresses retailers, and its shoes include many ... discounts on that day: Everything at Tbdress.com is up to ... $89). , People can use the following coupon codes as ...
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 ... allege heart attacks, strokes, deep vein thrombosis and ... in a federal multidistrict litigation (MDL) underway in ... reports. , Court documents updated on November ... Litigation (JPML) show the filing of 259 lawsuits ...
(Date:11/23/2014)... Nov. 23, 2014 (HealthDay News) -- The holidays can ... because sensory overload can trigger major meltdowns, an expert ... the best of circumstances, but when you have children ... Gibbs, an occupational therapy professor at University of the ... "It,s best to let your hosts or visitors ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... the market such as its significance, programs and ... globally and Chinese suppliers major market gamers in ... company information, item specifications, prospective, manufacturing value, and ... statistical research, the evaluation symbolizes the globally and ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 SWAccessControl.com's high ... global market. Recently, the company has announced its new ... special offer on these high quality power suppliers. All ... 30% off. The special offer lasts until Dec. 20, ... many of them have been supporting it for a ...
Breaking Medicine News(10 mins):Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2
... State University biologist continue to collaborate with the Harvard ... of a certain cellular process that can play a ... K-State associate professor in the Division of Biology, received ... Institute of General Medical Sciences through Recovery Act funding. ...
... 21 One in eight women will be diagnosed with breast cancer ... common type of cancer among women in the United States. Early detection ... one diagnosis is 98 percent. Stage two still has a very high ... the story here: http://www.mediaseed.tv/Story.aspx?story=37000 , , ...
... LONDON, Sept. 21 /PRNewswire-FirstCall/ - Equity Capital ... a preliminary review of the HTDS business ... to all HTDS followers at the following ... Management PLC, (ECM) believes that in the ...
... , KANSAS CITY, Mo., Sept. 21 Public ... recommend seasonal influenza vaccination as the first line of defense this ... The American Lung Association of the Central States is kicking ... City and is supporting local public health efforts to get Greater ...
... , , BEDFORD, Mass., Sept. ... their "Passion & Results" Award. The winners were presented with ... International Society on Thrombosis and Haemostasis (ISTH) held in Boston, MA, ... for Clinical Chemistry (AACC), in Chicago, IL, July 19-23. ...
... from dementia , MONDAY, Sept. 21 (HealthDay News) -- ... pace, and by next year 35.6 million people around the ... since 2005, a new report predicts. , Incidence of ... in 2030 and 115.4 million in 2050, according to ...
Cached Medicine News:Health News:Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS) 2Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 2Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 3Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 4Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 5Health News:Instrumentation Laboratory Announces 'Passion & Results' Award Winners 2Health News:Instrumentation Laboratory Announces 'Passion & Results' Award Winners 3Health News:Instrumentation Laboratory Announces 'Passion & Results' Award Winners 4Health News:Alzheimer's Soars, Global Focus Needed: Study 2Health News:Alzheimer's Soars, Global Focus Needed: Study 3
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Medicine Products: